20/09/2026
Nature Reviews Cancer: Immunotherapy remains largely ineffective in gliomas despite success in other cancers. In this Review, Britta Engelhardt and Michael Platten outline how central nervous system immune privilege is enforced by specialized brain barriers that restrict T cell surveillance and discuss strategies to overcome these barriers to improve T cell-based immunotherapy for glioma.
Link to the Review in the comments.